University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

The McCAVE Trial : Vanucizumab plus mFOLFOX-6 Versus Bevacizumab plus mFOLFOX-6 in Patients with Previously Untreated Metastatic Colorectal Carcinoma (mCRC)

dc.contributor.authorBendell, Johanna C.
dc.contributor.authorSauri, Tamara
dc.contributor.authorGracian, Antonio Cubillo
dc.contributor.authorAlvarez, Rafael
dc.contributor.authorLopez-Lopez, Carols
dc.contributor.authorGarcia-Alfonso, Pilar
dc.contributor.authorHussein, Maen
dc.contributor.authorLimon Miron, Maria-Luisa
dc.contributor.authorCervantes, Andres
dc.contributor.authorMontagut, Clara
dc.contributor.authorSantos Vivas, Cristina
dc.contributor.authorBessudo, Alberto
dc.contributor.authorPlezia, Patrica
dc.contributor.authorMoons, Veerle
dc.contributor.authorAndel, Johannes
dc.contributor.authorBennouna, Jafaar
dc.contributor.authorvan der Westhuizen, Andre
dc.contributor.authorSamuel, Leslie
dc.contributor.authorRossomanno, Simona
dc.contributor.authorBoetsch, Christophe
dc.contributor.authorLahr, Angelika
dc.contributor.authorFranjkovic, Izolda
dc.contributor.authorHeil, Florian
dc.contributor.authorLechner, Katharina
dc.contributor.authorKrieter, Oliver
dc.contributor.authorHurwitz, Herbert
dc.contributor.institutionUniversity of Aberdeen.Aberdeen Centre for Evaluationen
dc.date.accessioned2020-03-17T10:25:01Z
dc.date.available2020-03-17T10:25:01Z
dc.date.issued2020-03
dc.descriptionWe thank the patients and their families for their participation in this study and the staff at the study sites. This study and editorial support for the preparation of this manuscript were funded by F. Hoffmann-La Roche Ltd. Support for third-party writing assistance for this article, furnished by Goran Westerburg, Ph.D., was provided by La Crocina Pharmaceutical Consultants Lp.en
dc.description.statusPeer revieweden
dc.format.extent9
dc.format.extent1033773
dc.identifier158966203
dc.identifier66c9e3dd-c631-48de-a3b0-234cb57deca2
dc.identifier85074443333
dc.identifier000488169200001
dc.identifier.citationBendell, J C, Sauri, T, Gracian, A C, Alvarez, R, Lopez-Lopez, C, Garcia-Alfonso, P, Hussein, M, Limon Miron, M-L, Cervantes, A, Montagut, C, Santos Vivas, C, Bessudo, A, Plezia, P, Moons, V, Andel, J, Bennouna, J, van der Westhuizen, A, Samuel, L, Rossomanno, S, Boetsch, C, Lahr, A, Franjkovic, I, Heil, F, Lechner, K, Krieter, O & Hurwitz, H 2020, 'The McCAVE Trial : Vanucizumab plus mFOLFOX-6 Versus Bevacizumab plus mFOLFOX-6 in Patients with Previously Untreated Metastatic Colorectal Carcinoma (mCRC)', Oncologist, vol. 25, no. 3, pp. e451-e459. https://doi.org/10.1634/theoncologist.2019-0291en
dc.identifier.doi10.1634/theoncologist.2019-0291
dc.identifier.iss3en
dc.identifier.issn1083-7159
dc.identifier.otherORCID: /0000-0002-8402-8670/work/79064869
dc.identifier.urihttps://hdl.handle.net/2164/13875
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85074443333&partnerID=8YFLogxKen
dc.identifier.vol25en
dc.language.isoeng
dc.relation.ispartofOncologisten
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectFirst-line metastatic colorectal canceren
dc.subjectAngiopoetin-2en
dc.subjectVEGF-Aen
dc.subjectVanucizumaben
dc.subjectBevacizumaben
dc.subjectBIOMARKERen
dc.subjectANTIBODYen
dc.subjectPHASE-IIen
dc.subjectOXALIPLATINen
dc.subjectANGIOPOIETIN-2en
dc.subjectANTITUMOR-ACTIVITYen
dc.subjectCOMBINATIONen
dc.subjectHYPERTENSIONen
dc.subjectAMG 386en
dc.subjectCLINICAL-OUTCOMESen
dc.subjectR Medicineen
dc.subjectOncologyen
dc.subjectCancer Researchen
dc.subjectSupplementary Dataen
dc.subject.lccRen
dc.titleThe McCAVE Trial : Vanucizumab plus mFOLFOX-6 Versus Bevacizumab plus mFOLFOX-6 in Patients with Previously Untreated Metastatic Colorectal Carcinoma (mCRC)en
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
bendell_et_al_TO_the_McCAVE_trial_VoR.pdf
Size:
1009.54 KB
Format:
Adobe Portable Document Format

Collections